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Timm Dickfeld, MD, PHD,*† Peng Lei, MA,* Vasken Dilsizian, MD,* Jean Jeudy, MD,*
Jun Dong, MD, PHD,† Apostolos Voudouris, MD,* Robert Peters, MD,* Magdi Saba, MD,*
Raj Shekhar, PHD,* Stephen Shorofsky, MD, PHD*
Baltimore, Maryland
O B J E C T I V E S This study sought to assess the feasibility of deriving 3-dimensional (3D) scar maps
from positron emission tomography (PET)/computed tomography (CT) hybrid imaging and to integrate
those into clinical mapping systems to assist in ventricular tachycardia (VT) ablations.
B A C KG ROUND Ablation strategies for nonidiopathic VT are increasingly based on the anatomic
information of the scar and its border zone. However, the current “gold standard” of voltage mapping
is limited by its inability to accurately describe a complex 3D scar morphology, its imperfect spatial
resolution, and prolonged procedure times.
METHOD S Fourteen patients underwent PET/CT multimodality imaging before the VT ablation. We
used PET/CT-derived scar maps to characterize myocardial scar using a 17-segment analysis and surface
reconstruction. In 10 patients, reconstructed 3D metabolic scar maps were integrated into a clinical
mapping system and compared with high-resolution voltage maps.
R E S U L T S A good correlation was found between the voltage maps and PET/CT-derived scar maps
(r  0.89; r  0.05). In addition, 3D metabolic scar maps accurately displayed endocardial and epicardial
surface and could be successfully integrated with a registration error of 3.7  0.7 mm. A combination
of visual alignment and surface registration was most accurate for myocardial scar accounting for 15%
of the left ventricular surface. Scar size, location, and border zone accurately predicted high-resolution
voltage map ﬁndings (r  0.87; p  0.05). Integrated scar maps revealed metabolically active channels
within the myocardial scar not detected by voltage mapping and correctly predicted non-transmural
scar despite normal endocardial voltage recordings. Areas of low voltage within wall segments
displaying preserved metabolic activity were shown to be due to suboptimal catheter contact and
prevented unnecessary ablation lesions.
CONC L U S I O N S We found that PET/CT fusion imaging is able to accurately assess left ventricular
scar and its border zone. The integration of a 3D scar map into a clinical mapping system is feasible and
may allow supplementary scar characterization that is not available from voltage maps. This technique
could signiﬁcantly facilitate substrate-based VT ablations. (J Am Coll Cardiol Img 2008;1:73–82) © 2008
by the American College of Cardiology Foundation
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74atients with internal cardiac defibrillators
present increasingly with frequent and appro-
priate shocks for ventricular tachycardia (VT)
(1,2). Because the use of antiarrhythmic medi-
ations frequently is limited by side effects and
ecreasing long-term efficacy, radiofrequency ablation
f VT is required in many of these patients (3–5).
Three-dimensional (3D) mapping systems have
acilitated “substrate modification” approaches,
hich are required in up to 90% of patients because
f hemodynamically unstable VT (3). These sys-
ems consist of placing tangential or radial ablation
ines along or across the scar border to interrupt
exit sites” or “slowly conducting channels” (3,6,7).
herefore, an exact intraprocedural knowledge of
he scar geometry and scar border is extremely
mportant for the correct placement of these cura-
ive lesions.
However, the current “gold standard” in electro-
physiology to define scar relies solely on
bipolar endocardial voltage measurements
of 0.5 mV (voltage mapping) to define
the myocardial scar (3,6,7). Unfortunately,
voltage mapping has several important
limitations. First, extensive mapping is
time-intensive. Second, a single endo-
cardial voltage measurement cannot ac-
curately describe a complex 3D scar
morphology and differentiate between
endocardial and epicardial scar compo-
nents. Third, suboptimal catheter contact
can result in falsely low-voltage measure-
ments, leading to an overestimation of the
ventricular scar and unnecessary ablation
esions. Fourth, the spatial resolution of the voltage
ap is limited to an 5 mm catheter mapping area
catheter tip  3.5 mm, interelectrode distance  1
m, and ring electrode  1 mm), which can make
he detection of small, localized scar components
ifficult. Additionally, time constraints in clinical
ractice can result in significantly lower mapping
ensity for large portions of the left ventricle (LV).
Hybrid positron emission tomography (PET)/
omputed tomography (CT) imaging has the po-
ential to address these limitations by obtaining
patially aligned corresponding datasets, which en-
ble complimentary anatomical and metabolic char-
cterization of myocardium in a single imaging
ession. The integration of PET/CT datasets into
linical mapping systems would allow the intrapro-
edural display of anatomically and metabolically
efined scar anatomy and scar borders to guide
se
r
tionubstrate-based VT ablations. (E T H O D S
ourteen consecutive patients with internal cardiac
efibrillators who were scheduled to undergo VT
blation were enrolled into this study. All protocols
ere reviewed and approved by the Institutional
eview Board at the University of Maryland.
ET/CT datasets. Studies were performed on a Philips
emini system (Phillips, Best, the Netherlands), and
ET images were obtained with the whole-body
amera perpendicular to the long axis to create trans-
xial tomograms. Approximately 1 h before the injec-
ion of 18-fluorodeoxyglucose (FDG), fasting patients
eceived an oral load of approximately 25 to 50 g of
lucose. A 3- to 4-min attenuation correction scan
as performed using a rotating Cesium-137 line
ource, which allowed averaging the PET emission
ata over many respiratory cycles, thereby minimizing
he potential inaccuracies of attenuation correction
ue to respiratory motion. Twelve millicuries of FDG
as injected, and data were acquired over the course of
5 to 30 min. Quantitative and qualitative myocardial
etabolic activity was evaluated using the PET data-
et to define myocardial scar. Regional blood flow and
arcolemmal integrity (as reflected by the Na-K-
TPase transport system) was assessed by a prepro-
edural rest-redistribution thallium scan or rubidium
ET. Those images were reconstructed analogously to
he FDG-PET images, to define myocardial regions
s scarred (FDG to blood flow match pattern), dis-
ased/hibernating/stunned (FDG to blood flow mis-
atch pattern), and normal.
The CT was performed with the integrated
6-slice multidetector CT system. The scans were
ontrast-enhanced with 100 ml of 350 Omnipaque
GE Healthcare, Fairfield, Connecticut) using ret-
ospective ECG gating. Scans were 120 kV, 500 to
00 mA, and 0.4-s rotation speed. The acquired
ata were reconstructed into 10 cardiac phases from
% to 90%. The CT datasets were processed at a
hilips Extended Brilliance Workspace to assess
natomic (wall thinning, intramural calcification,
neurysm) abnormalities consistent with myocardial
car. Then, PET/CT datasets were fused using the
nternal Phillips Gemini or external custom-made
oftware (8).
oltage map. Voltage maps were created in all 14
atients by an electrophysiologist who was blinded
o the PET/CT datasets. Voltage maps were ob-
ained using a clinical 3D-mapping system using
ither a 4-mm tip (RPM, Boston Scientific, Natick,
assachusetts; 4 patients) or 3.5-mm tip catheterB B R E V I A T I O N S
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75ew York, New York; 10 patients) using a filling
hreshold of 15 mm. Bipolar electrograms were
ltered at 10 to 30 to 400 to 500 Hz. Standard
linical voltage settings of0.5 mV, 0.5 to 1.5 mV,
nd 1.5 mV were used for scar, abnormal, and
ormal myocardium, respectively (3).
omparison of voltage map and PET/CT. Voltage map
nd PET/CT images of all 14 patients were sec-
ioned into standardized 17-segment maps, which
s consistent with the current American Heart
ssociation guidelines for quantitative comparison
Fig. 1) (9). For additional analysis, the PET
mages underwent a 3D reconstruction (Emory
oolbox, GE Healthcare), which displayed the
etabolic signal intensities analogously to the volt-
ge map and allowed their correlation with the
Figure 1. Fusion of 18-Fluorodeoxyglucose Positron Emission To
Contrast-enhanced computed tomography (CT) demonstrates all ca
fact of internal deﬁbrillator lead (M) in right atrium. Signiﬁcant wall
ing with myocardial infarction (top panels). A matching decrease in
images obtained with positron emission tomography. Preserved me
served metabolic activity (A) within the lateral wall, which appears
dium within the infarcted area (middle panels). Positron emission t
allow the visualization of metabolic and anatomic datasets. The left
further analysis with the use of a conventional 17-segment model (orresponding CT images (Fig. 2). tD scar map reconstruction and integration. The
apping system used in the first 4 patients did not
llow image integration (RPM, Boston Scientific).
n the other 10 patients, the axial PET dataset
nderwent post-procedural DICOM3 formatting
nalogous to the CT or magnetic resonance imag-
ng (MRI) datasets to allow recognition by the
roprietary CartoMERGE software (Biosense
ebster, Diamond Bar, California). The PET
ataset was transferred from a CD using the Carto-
ERGE Image Importation algorithm. Using the
artoMERGE Image Processing tool, we adjusted
he upper and lower thresholds to color-code LV
yocardium, which was determined as viable by a
oard-certified nuclear cardiologist on the raw data-
et using a 50% metabolic activity cut-off. After
seed” placement, the 3D cardiac model was ex-
graphy and CT Images
c chambers (right ventricle [RV]; left ventricle [LV]) and metal arti-
ning (arrows) was noted in the apical and lateral LV wall consist-
nal intensity in apical and lateral wall segments was observed in
lism of papillary muscle (P) was noted. Note the areas of pre-
ormly thinned by CT images and may represent surviving myocar-
graphic images are fused with corresponding CT datasets to
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76ight ventricular and noncardiac structures were
emoved with the CartoMERGE clipping tools.
sing the CartoMERGE export function, the 3D
odel was saved for the clinical study.
After creating an LV electroanatomical map, the
Comparison of Voltage Map With Positron Emission
hy/Computed Tomography
ensional voltage map of the left ventricle in different projections.
l voltage is displayed color-coded according to scale. Myocardial scar
red representing voltage of 0.5 mV and appears to extend to the
(white arrow). (B) Corresponding projections of metabolic 3-dimen-
ron emission tomographic metabolic map. A color-coded scale with
metabolic activity from healthy myocardium (orange) to scar
monstrates good correlation with apical-septal-lateral scar deﬁned by
pping. However, a metabolically active area is found at the inferior
ge-purple area indicated by white arrow), which was not detected
e of voltage maps and could represent potential ventricular tachy-
nels. Corresponding contrast-enhanced computed tomography dem-
omogeneous wall thinning along the inferior wall (C, white arrow).xported study was uploaded with the regular Carto-ERGE algorithm. “Registration,” which de-
cribes the process of superimposing the extracted
ET scar map with the electroanatomical map, was
erformed either by obtaining 3 matching landmark
airs (at a 6- and 12-o’clock position of the mitral
alve and apex) or by using visual alignment after
pproximating both maps (using 12-o’clock posi-
ion of the mitral valve). Several different registra-
ion strategies were evaluated by performing either
andmark point registration alone, landmark point
egistration with surface registration (SURF), visual
lignment, and visual alignment with SURF. The
egistration quality was evaluated by visual assess-
ent of the voltage map/3D scar map alignment,
nternal summation statistics, and individual point-
o-shell distances. Area and distance measurements
n the voltage and 3D scar maps were performed
sing the internal CartoMERGE software.
tatistics. Statistical analysis was performed using
PSS for Windows (release 10.07, SPSS Inc., Chicago,
llinois). Continuous variables are expressed as mean
1 SD unless noted otherwise. Comparisons were
erformed using a 2-tailed, 2-sample t test (analysis of
ariance). The Pearson correlation coefficient was per-
ormed to assess possible correlations. Differences were
onsidered significant at a level of p  0.05.
E S U L T S
atient characteristics. Patient characteristics are
hown in Table 1. All 12 patients with ischemic
ardiomyopathy had a transmural infarction. The 2
atients with nonischemic cardiomyopathy had an
nferior, transmural scar and a nontransmural lateral
car, respectively.
lectrophysiological mapping. Endocardial maps
ere created in all 14 patients with 194 32 mapping
oints. Endocardial voltage mapping in the 12 pa-
ients with ischemic cardiomyopathy-delineated ho-
Table 1. Patient Characteristics at Time of Ventricular
Tachycardia Ablation
Age, yrs 61  12
Male gender, % 79
Ischemic cardiomyopathy, % 86





































































arrow, C). PET  positron emission tomography.
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77ogenous myocardial scar in the anterior (n  4),
nteroseptal (n 2), inferior (n 4), and lateral wall
n  2), whereas nonischemic patients showed infe-
ior (n 1) or no endocardial scar (n 1). In the last
atient additional epicardial mapping was performed
421 points), which demonstrated an epicardial lateral
car.
ET/CT imaging. We successfully performed PET/
T imaging and image fusion in all 14 patients; the
se of PET/CT allowed the preprocedural identi-
cation of the LV scar. Scar, as defined with PET,
orrelated well with wall thinning on the CT
mages (r  0.87; p  0.01). Aneurysm and
ntramyocardial calcification were each observed in
patients, respectively. Fused PET/CT images
evealed metabolically viable myocardium within
reas of wall thinning in 3 patients (Fig. 1). The
resence of intramyocardial calcium detected by CT
redicted a lack of metabolic activity by PET and
car by voltage map in all segments.
omparison voltage map versus PET/CT. Areas de-
ned as scar (0.5 mV) by voltage map corresponded
n PET/CT images to a metabolic signal count of 42
7% (range 31% to 56%) and demonstrated myo-
ardial wall thinning or lack of contractility on CT in
2% (Fig. 2). Abnormal myocardium with a voltage of
.5 to 1.5 mV exhibited a metabolic count of 67 
5% (range 48% to 92%) and displayed a variable
egree of wall thinning. Healthy myocardium (1.5
V) demonstrated a metabolic count of 86  12%
range 69% to 100%) and showed normal wall thick-
ess in 97%. A threshold of 50% metabolic activity
ad a sensitivity of 89% and a specificity of 93% to
redict myocardial scar defined by voltage.
The scar surface area, location, and geometric scar
hape correlated well between the voltage map and
ET data (Fig. 2). Voltage mapping demonstrated a
yocardial scar area of 32.6  22.1 cm2 with an LV
car burden of 11.7  23.4%, whereas the PET-
efined scar measured 29.1  24.0 cm2 with a scar
urden of 10.0  21.4% (r  0.89, p  0.05).
aximum and minimum distance across scar area was
.9  3.1 cm versus 6.8  2.7 cm and 3.8  1.7 cm
ersus 3.6 1.5 cm for the voltage map and metabolic
car map, respectively (r  0.89 and r  0.87).
The CT criteria (wall thinning/contractility) corre-
ated less well with scar area and diameter (r  0.74
nd r 0.77, respectively). In 2 of the patients with an
nferior myocardial infarction, a channel of metaboli-
ally alive tissue was found along the mitral valve ring,
hich had not been demonstrated by the voltage mapFigure 3. Volume Reconstruction of PET-Derived
3-Dimensional Scar Map in Clinical Mapping System
The left ventricle is observed as an ocher-colored reconstruction
from basal orientation as indicated by the cardiac icon in the lower
left corner. Three-dimensional reconstruction allows the visualiza-
tion of epicardium but also from endocardium, which can be visu-
alized through the mitral valve plane. Basal, left lateral wall defect
is seen as a “hole” in the reconstruction signifying myocardial scar
(white arrow, A). A left lateral view allows the visualization of the
epicardium with obvious wall defect due to the myocardial scarring
described previously (white arrow, B). A right anterior oblique view
(B): the “clipping” of the left ventricle allows the visualization of the
epicardium and endocardium and demonstrates the corresponding
myocardial thickness (En endocardial surface; Ep  epicardial
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78ntegration of 3D scar map (n  10). Transfer, extrac-
ion, and segmentation of the LV from the PET
atasets were successfully performed in all 10 cases
sing the CartoMERGE mapping system. The re-
ulting 3D scar map displayed the endocardial and
picardial surface and defined the myocardial wall and
hickness (Fig. 3). Because the current version of
artoMERGE only allows a binary display (absent or
resent voxel), myocardial scar had to be displayed as
bsent myocardium (i.e., “hole in the wall”). However,
his approach accurately reflected the location and size
f the myocardial scar and border zone as assessed by
he reading of a nuclear cardiologist.
In 4 of 10 patients, 4.1  2.3 abnormal voltage
easurements (0.6  0.3 mV) within metabolically
ormal myocardium were shown on repeat measure-
ent to have voltages 1.5 mV despite initial radio-
ogical appearance suggesting good catheter contact.
onsistently good registration results could be
chieved with visual alignment resulting in a position
rror of 3.7 0.7 mm (Table 2). The only individual
oint-shell distances 10 mm were observed within
he myocardial scar as they were measured to the scar
ap border zone (Fig. 4). The addition of SURF
mproved the registration accuracy to 3.3 0.3 mm in
atients with 15% of scar burden. However, the
arge infarcts in Patients #5, #7, and #8 resulted in
ignificant wall defects in the integrated scar maps,
hich impaired the accuracy of the surface registration
lgorithm (overall position error of 4.4  2.1 mm).
Landmark point registration alone demonstrated a
osition error of 11.2  3.9 mm using apical and
itral valve points. The addition of SURF improved
Table 2. Position Error: Individual Average Position Error as Ass
Patient After Different Registration Algorithms











Mean  SD 11.2  3.9 8.0
Mean  SD* 6.0
*Results if patients with large infarcts had been excluded (Patients #5, #7, #8).
LMPR  landmark point registration; SURF  surface registration; VA  visuhe position error to 8.0  3.5 mm (Table 2). Tilting lrrors of up to 15 mm, long-axis shifts of up to 11
m, and rotational errors of up 13 mm could be
inimized by adding visual alignment as part of the
egistration method.
After registration the voltage map-defined scar size
nd borderzone demonstrated an overall good corre-
ation with 3D scar map in patients with endocardially
etected scar (r  0.86, r  0.87, respectively; p 
.05) (Fig. 5). In these patients, scar voltage map
oints (0.5 mV) were within the metabolic scar area
n 89%, with an additional 8% being within an
djacent 1- to 1.5-cm border zone. Voltage measure-
ents within the PET-defined scar area demon-
trated a voltage amplitude of only 0.3  0.12 mV
ompared with 7.9 5.4 mV in the area with normal
etabolic activity (p  0.001).
upplementary scar characterization. Metabolically
iable myocardium was observed crossing an area of
ateral myocardial scar as defined by voltage map-
ing. Despite repeat attempts by 2 electrophysiolo-
ists and transseptal as well as retrograde aortic
ccess, no endocardial amplitude of 0.5 mV could
e recorded (Fig. 6). Additionally, the 3D meta-
olic map diagnosed myocardial scar despite a
ormal endocardial voltage map. Epicardial map-
ing confirmed a large, nontransmural inferobasal
car, which was consistent with the exit site of the
bserved clinical VT (Fig. 7).
I S C U S S I O N
he novel findings of this study are that: 1)
ET/CT fusion imaging can accurately predict
ed by CartoMERGE Internal Summation Statistics for Each
Registration Method
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79ompared with the current “gold standard” of volt-
ge mapping; 2) current image integration systems
an be modified to accept, register, and display 3D
olume datasets; and 3) integration of PET scar
aps can provide complimentary scar characteriza-
ion not available from conventional, endocardial
oltage mapping.
ardiac imaging of myocardial scar. We used PET or
ET/CT imaging for scar imaging in this study
ecause they are not affected by the same restric-
ions as MRI or CT alone. Although delayed-
nhanced MRI has been well-established to visual-
ze scar tissue (11,12), defibrillators, metal artifacts,
nd the association with nephrogenic systemic scle-
osis limit its use in the VT patient population
13–15). Similarly, although scar imaging with
elayed-enhanced CT has been described, its ap-
licability in chronic human infarcts is still evolving
16,17).
Positron emission tomography has been extensively
alidated for the detection of myocardial scar (18,19),
nd its prognostic value for cardiac interventions and
ardiac surgery has been shown repeatedly (20,21).
his study extends this observation and showed that
ET and PET/CT imaging can accurately predict the
ocation of nonviable (scar) versus viable LV myocar-
ium. The combination of PET and CT is especially
ttractive in this context because the submillimeter
esolution of the CT images can further improve the
patial resolution of the combined imaging data set.
mage integration of a 3D scar map. This study dem-
nstrates the ability to integrate 3D volume datasets
nto a clinical mapping system. Current image
ntegration systems only extract a “paper-thin” sur-
ace reconstruction representing the blood-
ndocardium interface (10). However, a clinically
seful 3D scar map requires a “volume display” of
he LV wall showing the endocardial/epicardial/
yocardial extent of the LV scar. As the current
artoMERGE software allows only a binary dis-
lay, scar had to be represented as absent voxels
esulting in a “hole.”
The available registration tools, especially visual
lignment and surface registration, were sufficient
o provide a registration accuracy of 3 to 4 mm,
hich is in the range of previous image integration
tudies (10,22–27). Surface registration was not
seful in patients with a large myocardial scar,
hich resulted in large LV wall “holes” for which
he current SURF algorithm cannot compensate.
After successful registration, this study found a
ood correlation between 3D scar map and voltageFigure 4. Registration Quality of 3-Dimensional Scar Map
Three-dimensional scar map (purple mesh) is superimposed and
registered to endocardial electroanatomic map (solid green)
using a visual alignment algorithm. The software of the clinical
mapping system displays for each endocardial point the dis-
tance to the registered positron emission tomography scar map
(green 5 mm, yellow 10 mm, and red 10 mm). Good over-
all registration quality is seen in right anterior oblique (A), left
lateral (B), and apical views (C), displaying green and yellow
markers. The only signiﬁcant registration error (red markers) is
found within the area of the apical scar. This error is due to the
absence of the positron emission tomography wall in areas of
scar (see the Methods section for further explanation), which
results in the software measuring the distance to the closest

























voltage-deﬁned myocardial scar (red, C). RV  right ventricular.
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80nd ablation. In our experience, a significant advan-
age of the scar map integration was the immediate
ecognition of falsely low-voltage recordings in
reas of normal metabolic activity. In all circum-
tances, they were shown to have resulted from
uboptimal catheter contact and thus prevented
nnecessary and possibly proarrhythmic ablation
esions. Additionally, the scar map was able to
rovide information about the location and extent
f the myocardial scar with a current spatial reso-
ution of approximately 5 to 6 mm. This accuracy
ould facilitate the detection of myocardial scar,
hich might be close to the highest possible reso-
ution of a 3.5-mm catheter tip and allowed the
lectrophysiologist to concentrate on scar areas and
order zones, which were thought to participate in
he VT.
With the use of a metabolic definition of cell
urvival, PET may provide a supplementary and
ossibly more sensitive way of assessing viable
yocardium than the electrically based voltage
apping. Indeed, in this study, 2 patients with
nferior infarct on the 3D scar map demonstrated
Alignment of Registered Endocardial Voltage Map and
onal Scar Map
displays endocardial voltage map using the conventional volt-
for endocardial scar of 0.5 mV displayed in red as seen in the
d scale displayed on the right. Superimposed 3-dimensional
mission tomographic scar map demonstrates a large apical wall
le) in the purple superimposed mesh signifying myocardial scar.
ﬁned myocardial scar and adjacent area of abnormal myocardial
reen and yellow) align well with the area of positron emission








voltage (ghannels of viable myocardium along the mitralFigure 6. Three-Dimensional Scar Map Demonstrating Viable
Myocardial Channel Across Lateral Scar
Endocardial voltage map demonstrates area of continuous lat-
eral scar as deﬁned by classical voltage criteria (red area) with
adjacent yellow-to-blue border zone (A). Positron emission
tomography-derived 3-dimensional scar map in corresponding
view conﬁrms a lateral scar (“hole”; see the Methods section)
but demonstrates a bridge of viable myocardium crossing the
presumed scar area (white arrow, B). After registration of volt-
age map and 3-dimensional positron emission tomographic scar
map, a bridge of metabolically alive tissue can be seen after
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81alve annulus, which were not detected with voltage
apping and can present successful ablation sites
28).
In another patient, PET displayed a channel of
iable myocardium crossing a lateral scar, which
ppeared homogeneously dense by voltage map-
ing. This discrepancy may represent endocardial
car, which results in low-voltage recordings, but
till has significant epicardial or mid-myocardial
urviving tissue that can be detected with PET. In
ddition, the use of PET enabled us to detect
ontransmural scarring in an area that appeared
ormal during endocardial voltage mapping and
ould only be confirmed with an epicardial mapping
pproach. Therefore, this technique may assist in
lanning the ablation strategies.
tudy limitations. Two different clinical systems were
sed for the acquisition of the voltage maps. Although
he use of 2 systems may have resulted in some
echnical variation, no obvious differences were appre-
iated. Second, the current CartoMERGE software
oes not contain quantitative tools to standardize the
hreshold selection, which defines myocardial scar.
his limitation may lead to significant interobserver
nd intraobserver variability. Currently, the Car-
oMERGE software is limited to a binary display
resenting scar as a “hole” in the wall. Additionally, it
s not possible to process fused datasets or to combine
different imaging modalities. Appropriate software
olutions are currently being developed. Finally, this
tudy evaluated the correlation and feasibility of 3D
car map integration. Although some immediate clin-
cal benefits were observed, this study did not system-
tically investigate the clinical outcomes of PET/CT
ntegration.
O N C L U S I O N S
he findings of this study suggest that the use of
ET/CT fusion imaging can enable accurate as-
essment of LV scar and its border zone. The
ntegration of a 3D scar map into a clinical mapping
ystem is feasible and allows supplementary scar
haracterization that is not available from endocar-
ial voltage maps. This difference could signifi-
antly facilitate substrate-based VT ablations.
eprint requests and correspondence: Dr. Timm Dickfeld,
epartment of Cardiology, University of Maryland, 22
outh Greene Street, Room N3W77, Baltimore, Mary-Figure 7. Three-Dimensional Scar Map Displaying Epicardial
Scar
Endocardial voltage map was unable to detect myocardial scar,
and all wall segments revealed 1.5 mV voltage (left lateral
view, A). However, 3-dimensional positron emission tomographic
scar map (ocher shell) reveals a large inferobasal lateral wall
defect signifying myocardial scar, which was consistent with the
exit site of the presenting ventricular tachycardia (white arrow,
B). An epicardial voltage map ﬁnally conﬁrmed a large, non-
transmural scar (red area, 0.5 mV) in the inferobasal lateral
location (white arrow, C). Registration of the epicardial voltage
map and 3-dimensional positron emission tomographic scar
map demonstrates good correlation between the epicardial volt-
age-deﬁned scar and the positron emission tomographic-deﬁnedand 21201. E-mail: tdickfel@medicine.umaryland.edu.
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